Insights On CONTRACT PHARMA MANUFACTURING

  1. Mastering Technology Transfers: Our Blueprint For Success 4/16/2025

    Uncover how this expert approach to process transfer supports reliable, scalable commercial manufacturing in the rapidly growing biopharmaceutical market.

  2. How The Tariffs Could Impact Your Drug Development Supply Chain 4/16/2025

    Explore how a fully integrated, U.S.-based supply chain strategy can help you navigate potential tariff risks, reduce complexity, and strengthen resilience in pharmaceutical development.

  3. Challenges In ADC Production - Consolidating Operations Under One Roof 4/15/2025

    Eurofins CDMO Alphora consolidates ADC development and manufacturing under one roof, streamlining processes, enhancing safety, and accelerating delivery of high-quality, clinically-ready antibody-drug conjugates.

  4. Transforming Rare Disease Drug Development For A Faster Cure 4/15/2025

    This comprehensive exploration aims to shed light on the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey.

  5. Control Strategies And Method Development For Nitrosamines In APIs And Drug Products 4/15/2025

    Explore regulatory insights, analytical strategies, and real-world case studies for effective nitrosamine control in APIs and drug products.

  6. A New Paradigm In T-Cell Lymphoma Treatment: CD5 CAR-NK 4/14/2025

    T-cell lymphomas are a complex and increasingly prevalent group of cancers with poor survival outcomes and limited effective treatments, underscoring an urgent need for innovative therapies and novel targets.

  7. ThioBridge™ Conjugates 4/14/2025

    Discover how Abzena’s ThioBridge™ technology is enabling the next generation of stable, scalable, and clinically advanced ADCs through site-specific conjugation.

  8. The Versatility Of ThioBridge™ Site-Specific Conjugation Technologies 4/14/2025

    Explore how advanced site-specific conjugation technologies are redefining the next generation of ADCs with enhanced stability, homogeneous DAR, and streamlined development.

  9. Friendshoring: A Strategic Shift In Pharma Supply Chains 4/11/2025

    To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models and seeking more resilient, forward-looking strategies.

  10. The Power Of AI To Improve Clinical Trial Monitoring 4/11/2025

    By analyzing patient data sets, AI enhances predictive analytics, supports real-time patient alerts, and strengthens continuous monitoring — improving the effectiveness of clinical trial oversight.